In contrast, vitamin K antagonists, exemplified by warfarin, could induce ferroptotic damage within RPE cells, promote the related vascular proliferation, and ultimately, exacerbate CNV lesions, a sequence of events associated with more pronounced and expeditious vision loss in AMD (148)
Administered as a once-weekly injection, Wegovy has been found to be highly effective in promoting weight loss
GLP-1 users are much more likely to report using mental health services
(This is quite common in the drug-development and launch process.) In the drugmaker-sponsored early trials, over 50% of participants lost more than 15% of their body weight
Tirzepatide is a new dual GIPR/GLP-1R agonist recently approved by both the European Medicines Agency and the FDA